S Aubrey Stoch (Aubrey Stoch)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Chronic Obstructive Pulmonary Disease

Hepatitis C Virus Infection

Top Venues

Clinical and translational science

Clinical pharmacology and therapeutics

International journal of chronic obstructive pulmonary disease

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ednan K Bajwa, Dawn Cislak, Amit Kumar, Dan Li, Eric J Messina, Tom Reynders, Jean-François Denef, Vasile Corcea, Ketan P Buch, Eseng Lai, S Aubrey Stoch
Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease 19 (2024)
Kelly E Duncan, Runcheng Li, Lata Maganti, Amit Kumar, S Aubrey Stoch, Geoffrey A Walford
Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies. Clinical and translational science 17 (1) (2024)
Ednan K Bajwa, Dawn Cislak, Amit Kumar, Dan Li, Eric J Messina, Tom Reynders, Jean-François Denef, Vasile Corcea, Ketan P Buch, Eseng Lai, S Aubrey Stoch
Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease 19 (2024)
Kelly E Duncan, Runcheng Li, Lata Maganti, Amit Kumar, S Aubrey Stoch, Geoffrey A Walford
Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies. Clinical and translational science 17 (1) (2024)
Kelly E Duncan, Runcheng Li, Lata Maganti, Amit Kumar, S Aubrey Stoch, Geoffrey A Walford
Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies. Clinical and translational science 17 (1) (2024)
Ednan K Bajwa, Dawn Cislak, Amit Kumar, Dan Li, Eric J Messina, Tom Reynders, Jean-François Denef, Vasile Corcea, Ketan P Buch, Eseng Lai, S Aubrey Stoch
Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease 19 (2024)
Geoffrey A Walford, Kelly E Duncan, Moises Hernandez, Pavan Vaddady, Marcus Hompesch, Linda Morrow, S Aubrey Stoch
A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin Dimer. Clinical pharmacology and therapeutics 112 (1) (2022)
Jesse C Nussbaum, Azher Hussain, Bennett Ma, K Chris Min, Qing Chen, Charles Tomek, Marian Iwamoto, S Aubrey Stoch
Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans. Pharmacology research & perspectives 10 (1) (2022)
Wei Gao, Andrea L Webber, Jill Maxwell, Melanie Anderson, Luzelena Caro, Chris Chung, André M M Miltenburg, Serghei Popa, Kristien Van Dyck, Larissa Wenning, Eric Mangin, Christine Fandozzi, Radha Railkar, Norah J Shire, Iain Fraser, Bonnie Howell, Andrew H Talal, S Aubrey Stoch
Fine-Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection. Clinical pharmacology and therapeutics 107 (6) (2020)
Julie A Stone, Jacqueline B McCrea, Rose Witter, Stefan Zajic, S Aubrey Stoch
Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis. British journal of clinical pharmacology 85 (6) (2019)
Maggie Liu, F Owen Fields, Judith S Prescott, Akintunde Bello, Nancy Bower, Salima Darakjy, James Hartke, Vivek Kadambi, Daniel Lapadula, S Aubrey Stoch, Mazin Derzi
Evaluation of Therapeutics for Severely Debilitating or Life-Threatening Diseases or Conditions: Defining Scope to Enable Global Guidance Development. Clinical pharmacology and therapeutics 107 (3) (2019)
Iain P Fraser, Naomi D Neufeld, Larry A Fox, Mark S Kipnes, Tracie L Miller, Philip S Zeitler, Henry Rodriguez, Jocelyn H Gilmartin, Susan J Lee, Jaclyn K Patterson, Xiujiang S Li, Lata Maganti, Wen-Lin Luo, Daniel A Tatosian, S Aubrey Stoch
A randomized clinical trial to evaluate the single-dose pharmacokinetics, pharmacodynamics, and safety of sitagliptin in pediatric patients with type 2 diabetes. Pediatric diabetes 20 (1) (2018)